Worth reading
50Recurring
0–100. This measures how worthwhile something is to read, not how good or bad the company is.Direction
Neutral
Direction inferred from the company’s description.Scale
23200
SharesWording
Definitive
How definitive the wording is.Details of issuance or disposal
Disposal of treasury shares as restricted stock compensation
Who receives how much
23,200 common shares of the Company (of which 9,700 shares are for eligible directors)
Directors of the Company and its subsidiaries (excluding outside directors and audit & supervisory board members), and executive officers under mandate of the Company (excluding those residing overseas)25 / 23,200 shares
The lower thin line represents the existing number of shares to which these shares will be added.
¥2,550 per share
Amount of funds to be raised
Total payment amount: ¥59,160,000 (estimated net proceeds: Not disclosed)
Total Stock-Based Compensation
Monetary remuneration claims: ¥59,160,000 (including ¥24,735,000 for eligible directors). The annual remuneration limit for monetary remuneration claims granted to eligible directors is ¥80 million or less.
Conditions on transfer restrictions
Restricted stock is stock awarded as compensation that cannot be sold during a specified period, with the restrictions lifted once the applicable conditions are met.
Transfer restriction period
From 10 August 2026 until the date on which the recipient ceases to hold the position of director or executive officer under mandate of the Company or its subsidiaries
Conditions for lifting transfer restrictions
Eligible directors and subsidiary directors must continuously hold the relevant position from the conclusion of the ordinary general meeting of shareholders immediately preceding the payment date through the conclusion of the ordinary general meeting of shareholders in the following year, while executive officers under mandate must continuously hold the relevant position throughout the prescribed service period. If a recipient leaves the position partway through the period for a legitimate reason, the number of shares subject to release and the release timing will be reasonably adjusted.
Reason for acquisition without consideration
If any shares remain subject to transfer restrictions when the transfer restriction period expires. This also includes cases in which shares remain subject to transfer restrictions in connection with a corporate reorganization or similar transaction.
Categories and Number of Persons Covered
25 directors of the Company and its subsidiaries (excluding outside directors and audit & supervisory board members) and executive officers under mandate of the Company, 23,200 shares (including eligible directors: 24 people, ¥9,700,000 equivalent in monetary remuneration claims and 9,700 shares)
Intended allottee's holding policy
During the transfer restriction period, the shares may not be transferred, pledged, made subject to a transfer security interest, gifted inter vivos, bequeathed or otherwise disposed of in any way. The shares will be managed in a designated account until the transfer restrictions are lifted.
Payment date
10 August 2026
Basis for determining the amount to be paid
The closing price of the Company's common shares on the Tokyo Stock Exchange on 15 July 2026, the business day preceding the date of the Board of Directors' resolution, was ¥2,550. Discount rate/premium rate: Not disclosed.
Impact on Business Performance
The specific impact on business performance is Not disclosed
| Item | Details |
|---|---|
| Type of issuance or disposal | Disposal of treasury shares as restricted stock compensation |
| Number of shares to be issued or disposed of | 23,200 common shares of the Company (of which 9,700 shares are for eligible directors) |
| Issue price and disposal price | ¥2,550 per share |
| Amount of funds to be raised | Total payment amount: ¥59,160,000 (estimated net proceeds: Not disclosed) |
| Payment date | 10 August 2026 |
| Intended allottee | Category Directors of the Company and its subsidiaries (excluding outside directors and audit & supervisory board members), and executive officers under mandate of the Company (excluding those residing overseas) / Number of Employees 25 / Number of Shares 23,200 shares |
| Intended allottee's holding policy | During the transfer restriction period, the shares may not be transferred, pledged, made subject to a transfer security interest, gifted inter vivos, bequeathed or otherwise disposed of in any way. The shares will be managed in a designated account until the transfer restrictions are lifted. |
| Basis for determining the amount to be paid | The closing price of the Company's common shares on the Tokyo Stock Exchange on 15 July 2026, the business day preceding the date of the Board of Directors' resolution, was ¥2,550. Discount rate/premium rate: Not disclosed. |
| Transfer restriction period | From 10 August 2026 until the date on which the recipient ceases to hold the position of director or executive officer under mandate of the Company or its subsidiaries |
| Conditions for lifting transfer restrictions | Eligible directors and subsidiary directors must continuously hold the relevant position from the conclusion of the ordinary general meeting of shareholders immediately preceding the payment date through the conclusion of the ordinary general meeting of shareholders in the following year, while executive officers under mandate must continuously hold the relevant position throughout the prescribed service period. If a recipient leaves the position partway through the period for a legitimate reason, the number of shares subject to release and the release timing will be reasonably adjusted. |
| Reason for acquisition without consideration | If any shares remain subject to transfer restrictions when the transfer restriction period expires. This also includes cases in which shares remain subject to transfer restrictions in connection with a corporate reorganization or similar transaction. |
| Categories and Number of Persons Covered | 25 directors of the Company and its subsidiaries (excluding outside directors and audit & supervisory board members) and executive officers under mandate of the Company, 23,200 shares (including eligible directors: 24 people, ¥9,700,000 equivalent in monetary remuneration claims and 9,700 shares) |
| Total Stock-Based Compensation | Monetary remuneration claims: ¥59,160,000 (including ¥24,735,000 for eligible directors). The annual remuneration limit for monetary remuneration claims granted to eligible directors is ¥80 million or less. |
| Impact on Business Performance | The specific impact on business performance is Not disclosed |
Items this document does not state (14)
Total issue valueEstimated issuance expensesSpecific use of fundsDilution RateTotal number of issued sharesExercise priceExercise periodNumber of Stock Acquisition RightsUnderwriter / lead underwriterOverallotmentStock Split RatioProcedures under the Corporate Code of ConductMost recent equity financingMajor shareholders after the offering
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.To provide an incentive for the sustained enhancement of the Company's corporate value and to further promote the sharing of value with shareholders.
How to read this page
This is not the documentKomori reads the disclosure the company filed and writes this summary. Figures are as stated by the company and are not audited.
Weight is not a verdictIt measures how much this changes what the company had already told the market. It is not a view on the shares.
Corrections happenIf the company reissues this disclosure, the page is rebuilt from the corrected version and the revision number moves up.